Scientists Reverse Brain Aging With Simple Nasal Spray Treatment
Texas A&M researchers develop therapy that calms brain inflammation and restores cognitive function after just two doses, raising hopes for dementia treatments.
Researchers at Texas A&M University have developed a groundbreaking nasal spray that appears to reverse brain aging by reducing chronic inflammation and restoring cellular energy systems. The experimental treatment showed remarkable results in studies, with memory and cognitive function improving for months after just two doses, offering new hope for treating age-related mental decline and neurodegenerative diseases like dementia and Alzheimer's.
The therapy targets "neuroinflammaging," a persistent low-level inflammation that develops in aging brains and interferes with memory, thinking, and the brain's ability to adapt to new situations. This chronic inflammation is considered a major contributor to neurodegenerative diseases, but the Texas A&M team believes they have found a way to reverse this previously irreversible process. The treatment uses microscopic biological particles called extracellular vesicles loaded with microRNAs, molecules that help regulate important biological processes in the brain.
Dr. Ashok Shetty, university distinguished professor and associate director of the Institute for Regenerative Medicine, led the research team along with senior scientists Dr. Madhu Leelavathi Narayana and Dr. Maheedhar Kodali. "Brain age-related diseases like dementia are a major health concern worldwide," Shetty explained. "What we're showing is brain aging can be reversed, to help people stay mentally sharp, socially engaged and free from age-related decline." Their findings were published in the Journal of Extracellular Vesicles.
The nasal delivery method represents a crucial breakthrough, allowing the treatment to bypass the brain's protective barrier and travel directly into brain tissue without invasive procedures. Once inside the brain, the therapy suppressed inflammatory systems including the NLRP3 inflammasome and cGAS-STING signaling pathways, both strongly linked to aging-related brain inflammation. The treatment also restored activity in mitochondria, the cellular structures responsible for producing energy that become damaged during aging and inflammation.
Beyond simply reducing inflammation, the therapy appeared to restore the brain's fundamental energy systems, leaving brain cells more efficient and less vulnerable to decline. The researchers observed improvements in memory formation, cognitive flexibility, and overall brain function that persisted for months after treatment. While the research is still in early stages, the dramatic results suggest that some aspects of brain aging may be more reversible than previously thought, potentially opening new avenues for treating age-related cognitive decline and neurodegenerative diseases.
